Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · Real-Time Price · USD
2.390
+0.140 (6.22%)
At close: Oct 2, 2025, 4:00 PM EDT
2.360
-0.030 (-1.26%)
After-hours: Oct 2, 2025, 6:07 PM EDT
Company Description
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Check-Cap Ltd.
| Country | Israel |
| Founded | 2004 |
| IPO Date | Feb 19, 2015 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 85 |
| CEO | David Lontini |
Contact Details
Address: 29 Abba Hushi Ave., P.O.Box 1271 Isfiya, 3009000 Israel | |
| Website | check-cap.com |
Stock Details
| Ticker Symbol | CHEK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001610590 |
| CUSIP Number | M2361E203 |
| ISIN Number | IL0011336851 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| David Lontini | Interim Chief Executive Officer and Chairman of the Board |
| Alan Lewis | Chief Financial Officer |
| Noa Reshef M.B.A. | Head of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 12, 2025 | 6-K | Report of foreign issuer |
| Sep 5, 2025 | 6-K | Report of foreign issuer |
| Aug 27, 2025 | 20-F | Annual and transition report of foreign private issuers |
| May 23, 2025 | 6-K | Report of foreign issuer |
| May 1, 2025 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 15, 2025 | 6-K | Report of foreign issuer |
| Dec 31, 2024 | 6-K | Report of foreign issuer |
| Dec 31, 2024 | 6-K | Report of foreign issuer |
| Dec 26, 2024 | 6-K | Report of foreign issuer |
| Dec 3, 2024 | 6-K | Report of foreign issuer |